TCGX Acquisition Corp.
Searching since IPO 2026-08-06- CIK 2137965
- TCGX
- IPO 2026-08-06
- 19 filings
- IPO Size
- $86.3M
- raised at the IPO
- Current Status
- IPO
- from its latest filing
- IPO Year
- 2026
- year it listed
Filings, by quarter
19 filings over 2 quarters; violet bars carry a milestone
- 26 Q2: 1 filing
- 26 Q3: 18 filings
- S-1 filed 26 Q2
- IPO 26 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
TCGX Acquisition Corp. is a blank-check company seeking an initial business combination, focusing on healthcare and healthcare-related industries, particularly life sciences and medical technology. It may also pursue a target located in Asia, including Hong Kong or the PRC.
Investment Focus
Healthcare, Biopharmaceuticals, Technology
Geographic Focus
Asia, Hong Kong, People’s Republic of China
Key Information
As the filings state it
- IPO Date
- 2026-08-06
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- SPAC Ticker
- TCGX
Stock Performance
TCGXTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2026-08-06 | $10.65 | |
| Current Price | 2026-10-16 | $12.30 | +15% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Chen Yu, a healthcare investor and TCGX founder with more than two decades of healthcare investing, company-building and operating experience. The TCGX-affiliated team brings science-driven healthcare investment experience, including substantial experience in China.